Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community-directed doxycycline delivery for onchocerciasis
ISRCTN95189962Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of doxycycline and ivermectin in onchocerciasis (2 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Community-level and infected-patient efficacy of doxycycline MDA followed by ivermectin MDA after four years. Started May 2011; status: completed.
02
Drugs
doxycyclineivermectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on ISRCTN95189962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN95189962.